EU regulator conditionally approves Abbott's purchase of St Jude

November 23, 2016 12:24 PM EST

The ticker and trading information for St. Jude Medical is displayed where the stock is traded on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., April 28, 2016. REUTERS/Brendan McDermid/File Photo


Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

BRUSSELS (Reuters) - The European Commission on Wednesday said it has given its conditional approval to U.S. medical device maker Abbott Laboratories' (NYSE: ABT) bid for peer St Jude Medical Inc (NYSE: STJ).

Reuters reported on Nov. 15 that the $25 billion deal was going to be cleared in Brussels.

The European Commission, the mergers regulator, said in a statement that its approval was conditional on "Abbott divesting two devices used in cardiovascular treatments."

(Reporting by Gabriela Baczynska)



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Reuters

Add Your Comment